| DESCRIPTION OF ENHANCEMENTS |
The Inbound Electronic Prescribing (eRx) enhancements delivered in this
The LOCK timeout was intentionally changed to 0.01 seconds for MbM for the
5. VistA Provider Suggestion
---------------------------------------------------------------------------
When matching eRx Provider to a corresponding VistA Provider before the
user is prompted for the VistA entry it will first be presented with
suggestion (if any) based on the following logic:
- Once a VistA Provider is matched and later validated to an eRx Provider it
is then "remembered"
- When a new eRx prescription is received for the same eRx Provider the
following options in order to assist MbM in the processing of high-volume
"remembered" VistA Provider(s) are then presented as suggestions for the
user to select, as shown below (Validate Patient Screen - Edit action):
Select Item(s): Next Screen// E Edit
- Below is an example for the Provider matching (Validate Provider Screen -
Edit action):
|Sugg. 1 of 1 - 08/08/23|
ERX PROVIDER VISTA PROVIDER|From eRx#: 123123 |
incoming eRx's:
__________________________________________________________________________
Name:AEXRFGRI,APSKACWHZ |Name:AEXRFGRI,APSKACWHZ
NPI :1144286097 |NPI :1073579710
DEA#:AA1216680 |DEA#:AA1216680
Phone #: 555-220-0303 |Phone #: (555) 220-0303
Address: |Address:
123 INTERNATIONAL RD |123 INTERNATIONAL RD
GREENVILLE, IL 66024 |GREENVILLE, IL 66024
__________________________________|_______________________________________
ACTION on SUGGESTION: (A)CCEPT (F)ORGET (E)XIT: EXIT//
- When presented with a suggestion the user is given 3 options: (A)ccept,
(F)orget or (E)xit:
ACCEPT - Accepts the suggested VistA Provider and matches it to the eRx
FORGET - Forgets this suggested VistA Provider so that it is not
presented again in the future to any user
EXIT - Exits and proceed to match the VistA Provider manually
If more than one suggestion exists, then a 4th option is included: (N)ext:
Complete Orders from eRx [PSO ERX FINISH]
ACTION on SUGGESTION: (A)CCEPT (F)ORGET (N)EXT (E)XIT: EXIT//
NEXT - Ignores the current suggestion and view the next one"
6. VistA Medication (Drug, Dosage, Qty, etc...) Suggestion
---------------------------------------------------------------------------
When matching the eRx Drug to a corresponding VistA Drug before the
user is prompted for the VistA entry it will first be presented with
suggestion (if any) based on the following logic:
eRx Holding Queue Processing [PSO ERX QUEUE PROCESSING]
- Once an eRx is accepted, it moves to the Pending Queue as a Pending Order.
After the Pending Order is finished it becomes an Active prescription. At
this point the software will "create a memory" of how the prescription was
entered (Drug, Dosage, Days Supply, Qty, # of refills, etc).
- When a new eRx prescription is received for the same eRx Drug, NDC
Code, SIG, Qty, Days Supply, # of Refills and Substitution allowance. the
"remembered" VistA fields are then presented as suggestions for the
user to select, as shown below (Validate Drug Screen - Edit action):
Complete Orders from OERR [PSO LMOE FINISH]
Select Item(s): Next Screen// E Edit
- Below is an example for the Provider matching (Validate Provider Screen -
Edit action):
|Sugg. 1 of 1 - 06/11/23|
RX MED VISTA MED |From Rx#: 2297913 |
____________________________________________________________________________
Drug: Meloxicam 15mg Tablet |Drug: MELOXICAM 15MG TAB
Substitution? YES Renewals? YES |Drug Message:
| NATL FORM (2/10)
____________________________________|_______________________________________
SIG: |SIG:
TAKE ONE TABLET PO EVERY SIX HOURS | TAKE ONE TABLET BY MOUTH ONCE DAILY
AS NEEDED | DAILY
____________________________________|_______________________________________
Provider Notes/Comments: |Provider Comments:
|
____________________________________|_______________________________________
2. eRx Provider Auto-Validation (MbM ONLY)
Quantity: 90 |Quantity: 180
Dispense Unit: |Dispense Unit: TAB
Qty Qualifier: Original Quantity |
____________________________________|_______________________________________
Days Supply: 23 Refills: 5 |Days Supply: 30 Refills: 11
____________________________________|_______________________________________
ACTION on SUGGESTION: (A)CCEPT (F)ORGET (E)XIT: EXIT//
- When presented with a suggestion the user is given 3 options: (A)ccept,
(F)orget or (E)xit:
---------------------------------------------------------------------------
ACCEPT - Accepts the suggested VistA data and matches it to the eRx
FORGET - Forgets this suggested VistA Provider so that it is not
presented again in the future to any user
EXIT - Exits and proceed to match the VistA Provider manually
If more than one suggestion exists, then a 4th option is included: (N)ext:
ACTION on SUGGESTION: (A)CCEPT (F)ORGET (N)EXT (E)XIT: EXIT//
patch include updates to the current eRx functionality to convert all
a) A new logic for auto-validating a VistA Providers for MbM sites is being
NEXT - Ignores the current suggestion and view the next one"
7. Patient Validation Screen
---------------------------------------------------------------------------
The content of the Patient Validation screen was completely re-arranged to
show the eRx Patient and the VistA Patient side-by-side. In addition, the
eRx Patient allergy list (received from the outside prescriber) will be
displayed as well as the ChampVA Rx Benefit eligibility (MBM sites only).
Besides displaying the patients side-by-side, a few other features were
introduced to make the screen more user friendly, such as:
added by this patch to assist MbM in the processing of high-volume
a) When there is a mismatch for field (e.g., Name, DOB, etc.) the content
of such field will display in reverse video in for both records, eRx
and VistA Patients.
b) The content will display in highlight in order to stand from the field
label.
Obs) These features depend on the terminal display settings being set
differently for reverse video and highlighted font in order for it
to work.
incoming eRx's. In order to auto-validate a provider the following
Below is an example of how the new screen will be displayed (without the
reverse or highlighted video features):
_________________________________________________________________________
eRx Reference #: 916 ChampVA Rx Benefit: ELIGIBLE
Status: AUTO-MATCHED/EDITED & VALIDATED by TEST,USER on 1/28/23@14:52:29
ERX PATIENT VISTA PATIENT
_________________________________________________________________________
Name: TEST,PATIENT BETA |Name: TEST,PATIENT BETA
DOB : APR 21, 1990 |DOB : APR 21,1990
SSN : 345781234 |SSN : 345-78-1234
conditions must be fulfilled:
Sex : MALE |Sex : MALE
Address: |Address:
123 PATIENT WAY | 123 PATIENT WAY
CHEYENNE,WY 82001 | CHEYENNE,WY 82001
Home Phone: 2172234567 |Home Phone: 217-223-4567
_______________________________________|_________________________________
Allergy: |Allergy:
NO ALLERGY ASSESSMENT | NO KNOWN ALLERGIES
_______________________________________|_________________________________
|Pharmacy Narrative:
_______________________________________|_________________________________
Weight(Kg): |Weight(Kg):
Height(cm): |Height(cm):
_______________________________________|_________________________________
8. Provider Validation Screen
---------------------------------------------------------------------------
The content of the Provider Validation screen was completely re-arranged to
show the eRx Provider and the VistA Provider side-by-side. In addition, the
Besides displaying the providers side-by-side, a few other features were
- eRx Providers was auto-matched to a VistA Provider
introduced to make the screen more user friendly, such as:
a) When there is a mismatch for field (e.g., Name, DEA#, etc.) the
content of such field will display in reverse video in for both
records, eRx and VistA providers.
b) The content will display in highlight in order to stand from the field
label.
Obs) These features depend on the terminal display settings being set
differently for reverse video and highlighted font in order for it
to work.
- eRx Provider last name matches VistA Provider last name
Below is an example of how the new screen will be displayed (without the
reverse or highlighted video features):
_________________________________________________________________________
Provider Validation Apr 16, 2023@17:52:07 Page: 1 of 1
eRx Reference #: 344422 eRx Patient: TEST,PATIENT
Status: AUTO-MATCHED
ERX PROVIDER VISTA PROVIDER
_________________________________________________________________________
Name: TEST,PROVIDER |Name: TEST,PROVIDER
- First letter of eRx Provider first name matches first letter of VistA
NPI : 1073579710 |NPI : 1073579710
DEA : AV4538419 |DEA : CC4796237 DEA EXP: 12/23/20
|
Address: |Address:
123 FAKE STREET SOUTH |123 FAKE STREET NORTH
FRISCO,TX 75033 |FRISCO,TX 75033
Tel: 555-222-3344 |Tel: (555) 222-3344
Fax: |Fax:
______________________________________|__________________________________
Provider first name
9. Drug Validation Screen
---------------------------------------------------------------------------
The content of the Drug Validation screen was completely re-arranged to
show the eRx Drug information and the VistA corresponding fields in a
side-by-side arrangement. In addition, the eRx Patient allergy list
(received from the outside prescriber) will be displayed as well as the
list of allergies from the VistA patient.
Besides displaying the information side-by-side, a few other features were
introduced to make the screen more user friendly, such as:
- Zip code for the eRx Provider matches the zip code for the VistA
a) When there is a mismatch for field (e.g., Drug Name, Qty, etc.) the
content of such field will display in reverse video for both fields,
eRx and VistA.
b) The content will display in highlight in order to stand from the field
label.
Obs) These features depend on the terminal display settings being set
differently for reverse video and highlighted font in order for it
to work.
of the MbM Class 3 modifications into Class 1. Below is summary of the
Provider
Below is an example of how the new screen will be displayed (without the
reverse or highlighted video features):
Drug Validation Aug 18, 2023@13:58:45 Page: 1 of 3
eRx Reference #: 123211 Date Written: 8/10/23 Effective Date:
Status: MANUALLY-MATCHED
ERX MED | VISTA MED
Allergy: |Allergy:
NO ALLERGY INFORMATION RECEIVED| NO KNOWN ALLERGIES
________________________________|_____________________________________
- eRx is not electronically signed (CS eRx)
Drug: BREZTRI AEROSPHERE 160 MCG|1)Drug: BREZTRI AEROSPHERE 160 MCG
-9MCG-4.8MCG/ACTUATION HFA|
AEROSOL INHALER |
Substitution? YES Renewals? YES|Drug Message:
| NATL FORM (10-01) (NDC)
________________________________|_____________________________________
SIG: |SIG:
Inhale 2 puffs twice a day by | INHALE 1 PUFF PSIV EVERY MORNING
inhalation route for 30 days. |
________________________________|_____________________________________
|2) Dosage: 1 PUFF
| Verb: INHALE
|Disp. Units:
| Noun:
| Route: NASAL
| Schedule: QAM
________________________________|_____________________________________
|3)Patient Instructions:
|
________________________________|_____________________________________
b) The Audit Log will display "AUTO-VALIDATED" to indicate that a provider
Provider Notes/Comments: |4)Provider Comments:
| TEST
________________________________|_____________________________________
|5)Pat. Status: OTHER FEDERAL
________________________________|_____________________________________
Quantity: 30 |6)Quantity: 30
Dispense Unit: | Dispense Unit: BX
Qty Qualifier: Original Quantity|
________________________________|_____________________________________
Days Supply: 30 Refills: 5 |7)Days Supply: 30 8)Refills: 5
was auto-validated, as seen in the example below:
________________________________|_____________________________________
|9)Routing: MAIL
________________________________|_____________________________________
|10)Clinic:
________________________________|_____________________________________
10. New action View History Log (HL)
---------------------------------------------------------------------------
This new action added eRx Holding Queue Display screen will allow the user
to view a comprehensive history of the eRx as it moves through the OP
application, including activities in Backdoor Pharmacy. Please, refer to
the user documentation for more information about this new option.
11. Batch Hold and Un-Hold Functionality
---------------------------------------------------------------------------
The current Hold and Un-Hold actions were modified to perform the following
additional function: every time a prescription is put on Hold or removed
from Hold, the software will check other prescriptions exist for that
patient that were sent by the same prescriber on the same day. If any is
found, the software will ask the user if they want to Hold (or Un-Hold)
New Value: PROVIDER,NAME(DEA#: AX1212543) - AUTO-VALIDATED
those additional eRx records as well, as shown below:
...
Select Action: Next Screen// H Hold
Select HOLD reason code: HAL NO ALLERGY ASSESSMENT
Additional Comments (Optional): TESTING BATCH HOLD
Updating...done.
The following prescriptions are from the same provider and received on the
same day:
PROVIDER: TEST,PROVIDER eRx RECEIVED DATE: JAN 28, 2023@10:57:14
ERX ID DRUG NAME PROVIDER STATUS
--------------------------------------------------------------------------
123011 GABAPENTIN 300MG CAP TEST,PROVIDER N
123012 CITALOPRAM HYDROBROMIDE 20MG T TEST,PROVIDER N
123013 IBUPROFEN 400MG TAB TEST,PROVIDER N
123014 ACETAMINOPHEN 325MG TAB TEST,PROVIDER N
Do you want to put them on HOLD-HAL? No// YES Updating...done.
c) The Single Patient list will identify such event (auto-validation) by
12. New Allergy Functionality Enhancements
---------------------------------------------------------------------------
Functionality related allergies is being improved through the following
modifications:
a) When matching or accepting validation of a VistA patient it will display
in the warnings if the VistA patient selected has no Allergy Assessment:
******************************* WARNING(S) *************************
by highlighting the letter "V" under the MATCHING/PR column.
VistA Patient does not have an Allergy Assessment.
***********************************************************************
MbM sites only:
--------------
i) User won't be able to accept validation of a VistA Patient that
does not have an Allergy Assessment.
ii) All the actionable records for the same eRx patient will be
automatically be put on Hold with the code HAL - NO ALLERGY
ASSESSMENT, the user will be notified as shown below:
change being delivered in this patch. For a more comprehensive description of
The following eRx record(s) have been put on Hold (HAL) because the
VistA Patient selected (OUTPATIENT,JLG ONE) does not have an Allergy
Assessment:
ERX ID DRUG NAME PROVIDER STATUS
-----------------------------------------------------------------------
123010 CETIRIZINE HCL 10MG TAB TEST,PROVIDER HAL
123011 GABAPENTIN 300MG CAP TEST,PROVIDER HAL
123012 CITALOPRAM HYDROBROMIDE 20MG T TEST,PROVIDER HAL
123013 IBUPROFEN 400MG TAB TEST,PROVIDER HAL
3. VistA Patient and VistA Provider Look-up (MbM ONLY)
123014 ACETAMINOPHEN 325MG TAB TEST,PROVIDER HAL
Type <Enter> to continue or '^' to exit:
b) A new screen titled 'Patient Allergies' was created to show the eRx
Patient allergies side-by-side with the VistA Patient allergies in
detail. This new Screen can be invoked by using the PA (Patient
Allergy) hidden action from the following screens:
- eRx Holding Queue Display Screen (eRx Holding Queue)
---------------------------------------------------------------------------
- Patient Validation Screen (eRx Holding Queue)
- Drug Validation Screen (eRx Holding Queue)
- Pending Order Orders Screen (Backdoor OP)
This new screen contains an action called VPA (VistA Patient Allergies),
which allows the user to update the VistA Patient Allegies without
leaving the option.
Note: In order to use the VPA action the VistA Patient has to have been
previously matched.
The VistA Patient and Provider lookup prompts have been modified to display
13.New Eligibility Functionality (MbM sites only)
---------------------------------------------------------------------------
Functionality related ChampVA Rx Benefit Eligibility is being improved
through the following modifications:
a) ChampVA Rx Benefit eligibility information will be displayed in the new
Patient Validation Screen in the Header section. It will have one of
these 3 possible Values: ELIGIBLE, NOT ELIGIBLE or SB (Spine Bifida).
b) When matching a VistA patient it will display in the warnings if the
VistA patient selected is not eligible for ChampVA Rx Benefit (soft-
different information for MbM sites only:
stop):
******************************* WARNING(S) *************************
VistA Patient is not eligible for ChampVA Rx Benefit.
***********************************************************************
c) It will not allow accepting validation of a matched VistA patient that
is not eligible for ChampVA Rx Benefit (hard-stop):
*******************************INVALID PATIENT*************************
- For the VistA Patient it displays:
VistA Patient is not eligible for ChampVA Rx Benefit.
***********************************************************************
d) When matching or accepting validation fo a VistA patient that is not
eligible for ChampVA Rx Benefit all the actionable records for the same
eRx patient will be automatically be put on Hold with the code HEL -
ELIGIBILITY ISSUES, the user will be notified as shown below:
The following eRx record(s) have been put on Hold (HEL) because the
VistA Patient selected (OUTPATIENT,JLG ONE) is not Eligible for ChampVA
Name, DOB, SSN, City and State
Rx Benefit:
ERX ID DRUG NAME PROVIDER STATUS
-----------------------------------------------------------------------
123010 CETIRIZINE HCL 10MG TAB TEST,PROVIDER HEL
123011 GABAPENTIN 300MG CAP TEST,PROVIDER HEL
123012 CITALOPRAM HYDROBROMIDE 20MG T TEST,PROVIDER HEL
123013 IBUPROFEN 400MG TAB TEST,PROVIDER HEL
123014 ACETAMINOPHEN 325MG TAB TEST,PROVIDER HEL
(e.g., AAQDY,BUDT LUSER 08/04/1954 101058613 PADDLETON,MD)
Type <Enter> to continue or '^' to exit:
14.Duplicate VistA Patient Check (MbM sites only)
---------------------------------------------------------------------------
A new check will be performed when the users selects a patient (Edit) or
Accept Validation of a previously selected patient. The software will check
whether potential duplicate VistA patients exist and if so it will warn the
user about it, as seen below (Patient Validation Screen):
Edit Patient (Soft Stop):
- For the VistA Provider it displays:
------------------------
...
P Print H Hold UH Un Hold
E Edit AV Accept Validation RJ Reject
Select Item(s): Edit// e Edit
VISTA PATIENT: PHWWDY,QLYJH H
1 PHWWDY,QLYJH H 01/31/1952 101021512 TOMBSTONE,ID
2 PHWWDY,QLYJH H 09/30/1930 101097105 CASA GRANDA,FL
3 PHWWDY,QLYJH H 05/04/1934 101068053 SHADY GROVE,DE
Name, City, State, DEA# and Exp. (if any)
CHOOSE 1-3: 1 PHWWDY,QLYJH H 01/31/1952 101021512 TOMBSTONE,ID
Enrollment Priority: Category: IN PROCESS End Date:
****************************** WARNING(S) *****************************
The following VistA Patient(s) has been identified as potential
duplicate(s):
42211-PHWWDY,QLYJH H 09/30/1930 101097105 CASA GRANDA,FL
42737-PHWWDY,QLYJH H 05/04/1934 101068053 SHADY GROVE,DE
**************************************************************************
eRx Patient VistA Patient
the changes please refer to the documents listed in the Documentation section
(e.g., AEXRFGRI,APSKACWHZ TORRINGTON,WY DEA#: AA4729919 (Exp: 01/01/24)
---------------------------------------+----------------------------------
Name:MAT1,TEST8 |Name:PHWWDY,QLYJH H
DOB :DEC 18, 2014 |DOB :JAN 31,1952
Sex :MALE |Sex :MALE
SSN :101127944 |SSN :101-02-1512
Phone #: 2251230718 |Phone #:
Address: |Address:
123 FAKE STREET #101 |3301 MC CONNELL DRIVE
PLANO,TX 75025 |TOMBSTONE,ID 12345
---------------------------------------+----------------------------------
Would you like to use this patient? NO//
Accept Validation (Soft Stop):
-----------------------------
...
Select Item(s): Next Screen// AV Accept Validation
******************************* WARNING(S) ***************************
The following VistA Patient(s) has been identified as potential
4. VistA Patient Suggestion
duplicate(s):
42211-PHWWDY,QLYJH H 09/30/1930 101097105 CASA GRANDA,FL
42737-PHWWDY,QLYJH H 05/04/1934 101068053 SHADY GROVE,DE
*************************************************************************
Would you like to mark this patient as VALIDATED?
Enter Yes or No: NO//
15.New option: eRx Holding Queue Processing [PSO ERX QUEUE PROCESSING]
---------------------------------------------------------------------------
This new option was created to replace the option Complete Orders from eRx
---------------------------------------------------------------------------
[PSO ERX FINISH]. The new option will have 100% of the functionality of the
replaced option and some additional feature such as:
a)Most of the prompts when entering the option have been converted into
User Preferences changed after loading the list and can be saved by each
user as their preferred View
b)The header part of the option was modified to display information about
the parameters used to compose the list, such as LOOK BACK DAYS, MAX.
QUEUE SIZE, ERX STATUS, etc.
When matching eRx Patient to a corresponding VistA Patient before the user
c)The Grouping by CS (Controlled Substances) have a new format, which
separates entries in the queue.
d)The user will be able to more easily switch views between the Patient
Centric and the Rx Medication queues via the PC and RX actions.
e)Queue Search/Filter adds 3 new options in the Patient Centric View: RX#,
VISTA PATIENT and MATCH STATUS.
In addition, the interface for performing searches was changed to display
is prompted for the VistA entry it will first be presented with suggestion
information about the selected filters, including in the header part of
the list. The current filters can easily be reset via the RF (Remove
Filters) action.
f)Queue Search/Filter adds 4 new options in the Medication View: RX#,
VISTA PATIENT, VISTA PROVIDER and MATCH STATUS.
g)The MATCH STATUS filter was added to the Patient Centric and Medication
View and it has 4 different choices shown below:
(if any) based on the following logic:
1 PATIENT FAIL - PATIENT NOT MATCHED
2 PROVIDER FAIL - PROVIDER NOT MATCHED
3 DRUG FAIL - DRUG NOT MATCHED
4 BASIC - PATIENT, PROVIDER AND DRUG MATCHED
1: Includes records where the patient has not been matched
2: Includes records where the provider has not been matched yet, but the
patient is matched
3: Includes records where the drug has not been matched yet, but the
patient and the provider are matched
4: Includes records with the patient, provider and drug matched
Note: For a VA Medical Center site the list of choice will display
differently:
1 PATIENT NOT MATCHED
2 PROVIDER NOT MATCHED
3 DRUG NOT MATCHED
4 PATIENT, PROVIDER AND DRUG MATCHED
- Once a VistA Patient is matched and later validated to an eRx Patient it
h)The header in the Patient Centric and Medication views will display
information about the selected filters, as shown below:
Rx Medication Queue Jan 28, 2023@15:46:17 Page: 1 of 1
LOOK BACK DAYS: 200 CS/NON-CS: BOTH (II-V) MAX. QUEUE SIZE: 999
FILTERED BY: 01/08/23-01/18/23|PATIENT(TEST,PATIENT)
_________________________________________________________________________
# PATIENT DOB DRUG PROVIDER STA REC.DAT
...
is then "remembered"
Note: The current filters can easily be reset via the RF (Remove Filters)
action.
i)Queue Sorting was streamlined to allow the user to quickly sort the list
through specific actions for each column and also allows for Descending
Sorting (not available in the replaced option).
j)The Change View (CV) action allows the user to reconfigure the way the
list is displayed and allows them to save the configuration to be applied
to que queue when they re-enter the option.
of this description.
k)A new action called Refresh (REF) was added to allow the user to
re-display the queue. This feature allows the user view the latest
'locks' from other users that have been placed since the queue was last
built.
l)A new action called Change Look Back Days (LBD) was created to quickly
allow the user to change the number of days to look back for records.
m)A new action called Next Patient (NP) was created to assist users in
- When a new eRx prescription is received for the same eRx Patient the
selecting the next eRx Patient on the queue to be worked on without too
many key strokes.
n)A new action called Show/Hide Details (DET) under the Single Patient
list will show/hide additional information about each one of the
eRx on the list. It will display Qty, # of Refills, Days Supply and the
SIG (medication instructions).
o)A new action called Include All Statuses (IAS) under the Single Patient
list will show/hide non-actionable statuses like Processed (PR),
"remembered" VistA Patient(s) are then presented as suggestions for the
Removed (RM), etc. Furthermore, a field on the header will indicate
which statuses are being displayed: ALL or ACTIONABLE only.
p)A new option is being added to the initial selection before entering the
The new option is called Workload Processing (WP) and it is designed for
processing the current workload in a FIFO (First In First Out) method.
Instead of loading a list of patients (PC Centric Queue) or Prescriptions
(Rx View), this option will automatically choose the patient with the
oldest record to be worked on and will load it for the user to process
their prescriptions. Once the user finishes processing the prescription
user to select, as shown below (Validate Patient Screen - Edit action):
for the first patient loaded they can choose the Next Patient (NP) action
to move on to the next patient. This option will use the ERX DEFAULT
LOOKBACK DAYS field (#10.2) in the OUTPATIENT SITE file (#59) to
determine which one is the patient with the oldest record on file that
needs to be worked on next. The record must be in one of these 3
statuses: New, In-Process or Wait.
Additionally, this option allows the user to work on patients with
specific records that match the criteria below (see g bullet above for
more information on each filter):
1 PATIENT FAIL - PATIENT NOT MATCHED
2 PROVIDER FAIL - PROVIDER NOT MATCHED
3 DRUG FAIL - DRUG NOT MATCHED
4 BASIC - PATIENT, PROVIDER AND DRUG MATCHED
5 ALL (NO FILTERS)
q)A new option was added to the Single Patient Queue: JB (Jump to
Backdoor). Instead of jumping to the Complete Orders from OERR [PSO LMO
FINISH] option it will jump to the Patient Prescription Processing [PSO
LM BACKDOOR ORDERS option.
Select Item(s): Next Screen// E Edit
r)Within the Rx Medication Screen (or Rx List View Screen) the user will
have the ability to easily filter the list by Message Type by selecting
one of the following hidden actions.
NEW New Rx's Only
CR Change Request Only
RXF Rx Refill Only
IE Inbound Errors Only
OE Outbound Errors Only
|Sugg. 1 of 1 - 08/08/23|
CA Cancel Rx's Only
CN Cancel Response Only
CX Change Response Only
RRQ Renewal Request Only
RRP Renewal Response Only
ALL All Message Types
Note: The same result can be accomplished via the SQ (Search Queue)
action and selecting #7 and then the specific message type.
ERX PATIENT VISTA PATIENT |From eRx#: 123123 |
s)The NDC code will now be printed under the eRx Drug in the output print
from the Print eRx action, as shown below:
...
***************PRESCRIPTION INFORMATION******************
eRx Drug: MELOXICAM 15MG TAB
NDC: 00378108901
eRx Written Date: MAR 17, 2023 eRx Issue Date:
...
t)The Remove eRx (RM) action will now work for eRx records that are
___________________________________________________________________________
currently on Hold. Before, the user had to Un-Hold the record before
removing it.
u)The Jump to OP (JO) action only allowed the user to 'jump' to Backdoor
Pharmacy option if the patient had pending orders to be finished. This
restriction is being removed by this patch.
16.INC25762338 - Broken eRx drug auto-match on RxRenewalResponses
---------------------------------------------------------------------------
The ticket above will be addressed by this patch. This issue was caused by
Name:OPEKXAQDY,XUISCSD |Name:OPEKXAQDY,XUISCSD F
PSO*7*706 released on December 12th, 2022. This patch moved the
auto-matching functionality of provider and drug from the Hub to VistA.
However, the VistA did not implement drug auto-matching for
RxRenewalResponse records forcing the users to match the VistA dispense
drug manually. This patch will fix the issue by extending the VistA
auto-matching functionality to RxRenewalResponse records as well.
17.Routing field edit enabled for CS eRx orders
---------------------------------------------------------------------------
Users will now be allowed to edit the Routing (Mail/Window) field for a CS
DOB :DEC 18, 1970 |DOB :DEC 18, 1970
eRx Pending order. Before, all field were un-editable in the OP Pending
Order Queue because an audit is not captured. However, the Remarks field
does not exist until created by the user in the OP Pending Order Queue.
18.New Pending Order side-by-side interface for eRx orders
---------------------------------------------------------------------------
Similar to the eRx Drug Validation screen shown above the view of a pending
order that originated from an eRx will be displayed differently in the
Patient Prescription Processing [PSO LM BACKDOOR ORDERS] and Complete
Orders from OERR [PSO LMOE FINISH] options. When these option identify the
Sex :MALE |Sex :MALE
pending order an eRx prescription it will automatically switch the display
of the data to a side-by-side viewing where the left side shows the eRx
prescription information (from the outside doctor) while the right-side
shows the VistA corresponding information.
Besides displaying the information side-by-side, a few other features were
introduced to make the screen more user friendly, such as:
a) When there is a mismatch for field (e.g., Drug Name, Qty, etc.) the
content of such field will display in reverse video for both fields,
eRx and VistA.
SSN :101127944 |SSN :101-13-4021
b) The content will display in highlight in order to stand from the field
label.
Obs) These features depend on the terminal display settings being set
differently for reverse video and highlighted font in order for it
to work.
Below is an example of how the new screen will be displayed (without the
reverse or highlighted video features) for a new eRx Pending Order:
Address: |Address:
Pending OP Orders (ROUTINE) Aug 18, 2023@14:22:27 Page: 1 of 6
SPLYFX,KUNLYS JELUAHT
PID: 101-02-4809 Ht(cm): 187.96 (12/28/2010)
DOB: APR 28,1947 (76) Wt(kg): 112.94 (01/07/2011)
SEX: MALE Non-VA Meds on File Last entry on 06/24/23
CrCL: 53.8(est.) (CREAT: 1.51mg/dL 12/16/10) BSA (m2): 2.39
-------------------------------------------------------------------------
ERX (123360) | VISTA PENDING ORDER
-------------------------------------------------------------------------
PATIENT MANUALLY-MATCHED | VALIDATED by TESTONE,USER01 on 8/17/23@14:51:21
123 FAKE STREET #101 | 123 FLAKE ST SUITE 101
Name: SPLYFX,KUNLYS JELUAHT |Name: SPLYFX,KUNLYS JELUAHT
DOB : APR 28, 1947 |DOB : APR 28,1947
SSN : 101024809 |SSN : 101-02-4809
Sex : MALE |Sex : MALE
__________________________________|_____________________________________
|Pharmacy Narrative:
|terbinafine ok x 90 days (5/06);
|ROSIGLITAZONE; PANTOPRAZOLE; ZOLPIDEM
__________________________________|_____________________________________
Allergy: |Allergy:
PLANO,TX 75025 | PLANO,TX 75025
NO ALLERGY INFORMATION RECEIVED | NO KNOWN ALLERGIES
__________________________________|_____________________________________
PROVIDER AUTO-MATCHED | VALIDATED by TESTONE,USER01 on 8/17/23@14:51:40
Name: BLACKSTAD,GONZALO |Name: BLACKSTAD,GONZALO W
NPI : 1891745550 |NPI : 1891745550
DEA : AV4538419 |DEA :
__________________________________|_____________________________________
DRUG MANUALLY-MATCHED | VALIDATED by TESTONE,USER01 on 8/17/23@14:51:55
Substitution? YES |1) Orderable Item: ***(N/F)***
Renewals? YES | PANTOPRAZOLE NA TAB,EC
Primary Phone: 0236663417 |
__________________________________|_____________________________________
Drug: |2) Drug: ***(N/F)***
PANTOPRAZOLE NA 40MG EC TAB | PANTOPRAZOLE NA 40MG EC TAB UD
|Drug Message:
| NATL N/F; INCREMENT OF 100s
__________________________________|_____________________________________
SIG: |SIG:
TAKE ONE TABLET BY MOUTH EVERY DAY| TAKE ONE TABLET BY MOUTH ONCE DAILY
__________________________________|_____________________________________
|3) *Dosage: 40 (MG)
__________________________________|_______________________________________
| Verb: TAKE
| Disp. Units: 1
| Noun: TABLET
| *Route: ORAL
| *Schedule: ONCE DAILY
__________________________________|_____________________________________
|4)Patient Instruction:
|
__________________________________|_____________________________________
Provider Notes/Comments: |Provider Comments:
ACTION on SUGGESTION: (A)CCEPT (F)ORGET (E)XIT: EXIT//
__________________________________|_____________________________________
|5) Pat.Status: OUTPATIENT CARE
__________________________________|_____________________________________
Date Written: AUG 10, 2023 |6) Issue Date: AUG 10,2023
Effective Date: |7) Fill Date: Sep 12, 2023
__________________________________|_____________________________________
Days Supply: 30 |8) Days Supply: 30
__________________________________|_____________________________________
Quantity: 30 |9) QTY (TAB): 30
Dispense Unit: |
Qty Qualifier: Original Quantity |
__________________________________|_____________________________________
Refills: 5 |10) Refills: 5
__________________________________|_____________________________________
|11) Routing: MAIL
__________________________________|_____________________________________
|12) Clinic:
__________________________________|_____________________________________
Provider: PROVIDER, TEST W |13)Provider: PROVIDER,TEST W
__________________________________|_____________________________________
1. Lock Timeout Change (MbM ONLY)
- The left column has information about the eRx Patient while the right
|14)Copies: 1
__________________________________|_____________________________________
|15)Remarks:
__________________________________|_____________________________________
eRx Received on 9/20/23@11:44 | Accepted by TEST,USER on 9/26/23@10:30
Below is an example of how the new screen will be displayed (without the
reverse or highlighted video features) for a renewal eRx Pending Order:
---------------------------------------------------------------------------
column has information about the VistA Patient. The 'Last Match' field
Prescription Renew Sep 12, 2023@14:28:50 Page: 1 of 1
OUTDYX,JALN ILAH <A>
PID: 101-16-5191 Ht(cm): 182.88 (02/24/2011)
DOB: JUN 21,1954 (69) Wt(kg): 93.44 (02/24/2011)
+--------------------------------------------------------------------------
PATIENT MANUALLY-MATCHED | VALIDATED by TESTONE,USER01 on 8/11/23@14:31:33
Name: VAMC,PATIENT8 |Name: OUTDYX,JALN ILAH
DOB : JUN 21, 1954 |DOB : JUN 21,1954
SSN : 101165191 |SSN : 101-16-5191
Sex : MALE |Sex : MALE
indicates the last time the VistA Patient was matched to the eRx Patient
_______________________________________|___________________________________
|Pharmacy Narrative:
_______________________________________|___________________________________
Allergy: |Allergy:
NO ALLERGY INFORMATION RECEIVED | Verified:
| IBUPROFEN,PERCODAN,VALIUM
_______________________________________|___________________________________
PROVIDER AUTO-MATCHED/EDITED | VALIDATED by TESTONE,USER01 on 8/16/23@14:49
Name: TESTONE,USER02 |Name: TESTONE,USER01
NPI : 1033270160 |NPI :
and validated. When a corresponding field does not match it will display
DEA : AV4538419 |DEA :
_______________________________________|___________________________________
DRUG MANUALLY-MATCHED | VALIDATED by TESTONE,USER01 on 8/16/23@14:50:55
Substitution? YES |Orderable Item:
Renewals? YES | MELOXICAM TAB
_______________________________________|___________________________________
Drug: |CMOP Drug:
MELOXICAM 7.5MG TAB | MELOXICAM 7.5MG TAB
|Drug Message:
| NATL FORM (2/10)
in reverse video.
_______________________________________|___________________________________
SIG: |SIG:
TAKE 1 TABS ORALLY ONCE DAILY | TAKE ONE TABLET BY BY MOUTH ONCE
| DAILY WITH FOOD - IF SPLITTING
| TABLET, SPLIT JUST PRIOR TO USE
_______________________________________|___________________________________
| *Dosage: 15 (MG)
| Verb: TAKE
| Disp. Units: 1
| Noun: TABLET
| *Route: ORAL
| *Schedule: ONCE DAILY-WITH FOOD
_______________________________________|___________________________________
|Patient Instruction:
| - IF SPLITTING TABLET, SPLIT JUST
| PRIOR TO USE
_______________________________________|___________________________________
Provider Notes/Comments: |Provider Comments:
_______________________________________|___________________________________
|Pat.Status: OUTPATIENT CARE
- When presented with a suggestion the user is given 3 options: (A)ccept,
_______________________________________|___________________________________
Date Written: AUG 09, 2023 |1) Issue Date: Aug 09, 2023
Effective Date: |2) Fill Date: Sep 12, 2023
_______________________________________|___________________________________
Days Supply: 30 |Days Supply: 30
_______________________________________|___________________________________
Quantity: 30 |QTY (TAB): 30
Dispense Unit: |
Qty Qualifier: Original Quantity |
_______________________________________|___________________________________
(F)orget or (E)xit:
Refills: 11 |3) Refills: 11
_______________________________________|___________________________________
|4) Routing: MAIL
_______________________________________|___________________________________
|5) Clinic:
_______________________________________|___________________________________
Provider: TESTONE,USER02 |6) Provider: TESTONE,USER02
_______________________________________|___________________________________
|7) Copies: 1
_______________________________________|___________________________________
|8) Remarks:
| RENEWED FROM RX # 2297959
_______________________________________|___________________________________
eRx Received on 9/20/23@11:44 | Accepted by TESTONE,USER01 on 9/26/23@10:30
19.Ticket INC28342622 - PSOERXR1 - DEA # display
---------------------------------------------------------------------------
After the release of patch PSO*7*545 it was reported that the VistA
Provider DEA# was no long being displayed on the eRx Holding Queue Display
screen. This addresses the problem.
ACCEPT - Accepts the suggested VistA Provider and matches it to the eRx
20.Ticket INC28554236 - Un-Accept/EC/HC Hold Issue
---------------------------------------------------------------------------
It was reported that an eRx record was wrongly automatically being marked
as PR (PROCESSED) after the user un-accepted an order from the Pending
Queue back into the eRx Holding Queue and a placed a Change Request for it.
The PR status was assigned as soon as the user removed the eRx record from
Hold.
---------------------------------------------------------------------------
FORGET - Forgets this suggested VistA Provider so that it is not
presented again in the future to any user
EXIT - Exits and proceed to match the VistA Provider manually
If more than one suggestion exists, then a 4th option is included: (N)ext:
ACTION on SUGGESTION: (A)CCEPT (F)ORGET (N)EXT (E)XIT: EXIT//
NEXT - Ignores the current suggestion and view the next one"
|
